Are there differences by sex in lung cancer characteristics at diagnosis? -a nationwide study

por prodriguez | Ene 1, 2021 | Publicaciones - CIMO-02

Ruano-Ravina, A; Provencio, M; de Juan, VC; Carcereny, E; Estival, A; Rodriguez-Abreu, D; Benitez, G; Lopez-Castro, R; Belver, M; Guirado-Risueno, M; Guirao-Rubio, C; Blasco, A; Massuti, B; Ortega, AL; Cobo, M; Mosquera-Martinez, J; de la Rosa, CA; Bosch-Barrera, J;...

Ibero-American Expert Consensus on Squamous Cell Carcinoma of the Head and Neck Treatment in Patients Unable to Receive Cisplatin: Recommendations for Clinical Practice

por prodriguez | Ene 1, 2021 | Publicaciones - CIMO-02

Falco, A; de Oliveira, TB; Cacicedo, J; Ospina, AV; Ticona, MA; Galindo, H; Pereira, MD; Aguilar-Ponce, JL; Rueda-Dominguez, A; Soria, T; Taberna, M; Iglesias, L; Sowley, T; Mesia, R – 2021

Osimertinib in advanced EGFR-T790M mutation-positive non-small cell lung cancer patients treated within the Special Use Medication Program in Spain: OSIREX-Spanish Lung Cancer Group

por prodriguez | Ene 1, 2021 | Publicaciones - CIMO-02

Provencio, M; Terrasa, J; Garrido, P; Campelo, RG; Aparisi, F; Diz, P; Aguiar, D; Garcia-Giron, C; Hidalgo, J; Aguado, C; Gonzalez, JG; Esteban, E; Gomez-Aldavari, L; Moran, T; Juan, O; Chara, LE; Marti, JL; Castro, RL; Ortega, AL; Moreno, EM; Coves, J; Pena, AMS;...

Atezolizumab Plus Chemotherapy for First-Line Treatment of Nonsquamous NSCLC: Results From the Randomized Phase 3 IMpower132 Trial

por prodriguez | Ene 1, 2021 | Publicaciones - CIMO-02

Nishio, M; Barlesi, F; West, H; Ball, S; Bordoni, R; Cobo, M; Longeras, PD; Goldschmidt, J; Novello, S; Orlandi, F; Sanborn, RE; Szalai, Z; Ursol, G; Mendus, D; Wang, LJ; Wen, XH; McCleland, M; Hoang, T; Phan, S; Socinski, MA – 2021

Osimertinib Maintenance After Definitive Chemoradiation in Patients With Unresectable EGFR Mutation Positive Stage III Non-small-cell Lung Cancer: LAURA Trial in Progress

por prodriguez | Ene 1, 2021 | Publicaciones - CIMO-02

Lu, S; Casarini, I; Kato, T; Cobo, M; Ozguroglu, M; Hodge, R; van der Gronde, T; Saggese, M; Ramalingam, SS – 2021

Avelumab plus standard-of-care chemoradiotherapy versus chemoradiotherapy alone in patients with locally advanced squamous cell carcinoma of the head and neck: a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial

por prodriguez | Ene 1, 2021 | Publicaciones - CIMO-02

Lee, NY; Ferris, RL; Psyrri, A; Haddad, RI; Tahara, M; Bourhis, J; Harrington, K; Chang, PMH; Lin, JC; Razaq, MA; Teixeira, MM; Lovey, J; Chamois, J; Rueda, A; Hu, CS; Dunn, LA; Dvorkin, MV; De Beukelaer, S; Pavlov, D; Thurm, H; Cohen, E – 2021